<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nano Medicine &#187; Gene therapy</title>
	<atom:link href="http://www.nanomedicine.tv/category/gene-therapy/feed" rel="self" type="application/rss+xml" />
	<link>http://www.nanomedicine.tv</link>
	<description></description>
	<lastBuildDate>Fri, 18 May 2012 05:10:50 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Genetic predictor of breast cancer response to chemotherapy</title>
		<link>http://www.nanomedicine.tv/gene-therapy/genetic-predictor-of-breast-cancer-response-to-chemotherapy.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/genetic-predictor-of-breast-cancer-response-to-chemotherapy.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/genetic-predictor-of-breast-cancer-response-to-chemotherapy.php</guid>
		<description><![CDATA[Chemotherapy is a major first line defense against breast cancer. However a patient&#039;s response is often variable and unpredictable. A study published in BioMed Central&#039;s open access journal BMC Medical Genomics shows that &#039;gene expression signatures&#039; for TOP2A and ?-tubulin can be used to predict the outcome of chemotherapy.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&#38;p=genetic+therapy&#38;eo=UTF-8]]></description>
			<content:encoded><![CDATA[<p>Chemotherapy is a major first line defense against breast cancer. However a patient&#039;s response is often variable and unpredictable. A study published in BioMed Central&#039;s open access journal BMC Medical Genomics shows that &#039;gene expression signatures&#039; for TOP2A and ?-tubulin can be used to predict the outcome of chemotherapy.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/genetic-predictor-of-breast-cancer-response-to-chemotherapy.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic Technologies Executes Settlement and License Agreement With GeneSeek Inc.</title>
		<link>http://www.nanomedicine.tv/gene-therapy/genetic-technologies-executes-settlement-and-license-agreement-with-geneseek-inc.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/genetic-technologies-executes-settlement-and-license-agreement-with-geneseek-inc.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/genetic-technologies-executes-settlement-and-license-agreement-with-geneseek-inc.php</guid>
		<description><![CDATA[MELBOURNE, AUSTRALIA&#8211; &#8211; In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited is pleased to report that it has executed a Settlement and License Agreement with GeneSeek Inc. &#8230;Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&#38;p=genetic+therapy&#38;eo=UTF-8]]></description>
			<content:encoded><![CDATA[<p>MELBOURNE, AUSTRALIA&#8211; &#8211; In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited is pleased to report that it has executed a Settlement and License Agreement with GeneSeek Inc. &#8230;Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/genetic-technologies-executes-settlement-and-license-agreement-with-geneseek-inc.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular subtypes and genetic alterations may determine response to lung cancer therapy</title>
		<link>http://www.nanomedicine.tv/gene-therapy/molecular-subtypes-and-genetic-alterations-may-determine-response-to-lung-cancer-therapy.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/molecular-subtypes-and-genetic-alterations-may-determine-response-to-lung-cancer-therapy.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/molecular-subtypes-and-genetic-alterations-may-determine-response-to-lung-cancer-therapy.php</guid>
		<description><![CDATA[( University of North Carolina School of Medicine ) A UNC-led team of scientists has shown for the first time that lung cancer molecular subtypes correlate with distinct genetic alterations and with patient response to therapy. These findings in pre-clinical models and patient tumor samples build on their previous report of three molecular subtypes of [...]]]></description>
			<content:encoded><![CDATA[<p>( University of North Carolina School of Medicine ) A UNC-led team of scientists has shown for the first time that lung cancer molecular subtypes correlate with distinct genetic alterations and with patient response to therapy. These findings in pre-clinical models and patient tumor samples build on their previous report of three molecular subtypes of non-small cell lung cancer and refines their &#8230;Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/molecular-subtypes-and-genetic-alterations-may-determine-response-to-lung-cancer-therapy.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic testing for drug intolerance</title>
		<link>http://www.nanomedicine.tv/gene-therapy/genetic-testing-for-drug-intolerance.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/genetic-testing-for-drug-intolerance.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/genetic-testing-for-drug-intolerance.php</guid>
		<description><![CDATA[Testing could prove an effective remedy to a widespread problem. But there may be hidden hazards to our privacy Three years ago, Theo Dingermann, a professor of pharmaceutical biology at Goethe University in Frankfurt, sent a glob of spit to the United States. For $200 a company there sequenced part of his genome using DNA from his [...]]]></description>
			<content:encoded><![CDATA[<p>Testing could prove an effective remedy to a widespread problem. But there may be hidden hazards to our privacy Three years ago, Theo Dingermann, a professor of pharmaceutical biology at Goethe University in Frankfurt, sent a glob of spit to the United States. For $200 a company there sequenced part of his genome using DNA from his cheek cells. The test revealed that if he were to take the &#8230;Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/genetic-testing-for-drug-intolerance.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Improved adult-derived human stem cells have fewer genetic changes than expected</title>
		<link>http://www.nanomedicine.tv/gene-therapy/improved-adult-derived-human-stem-cells-have-fewer-genetic-changes-than-expected.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/improved-adult-derived-human-stem-cells-have-fewer-genetic-changes-than-expected.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/improved-adult-derived-human-stem-cells-have-fewer-genetic-changes-than-expected.php</guid>
		<description><![CDATA[( Johns Hopkins Medical Institutions ) A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cells &#8212; so-called induced pluripotent stem cells &#8212; and found that relatively few genetic changes occur during stem cell conversion [...]]]></description>
			<content:encoded><![CDATA[<p>( Johns Hopkins Medical Institutions ) A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cells &#8212; so-called induced pluripotent stem cells &#8212; and found that relatively few genetic changes occur during stem cell conversion by an improved method.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/improved-adult-derived-human-stem-cells-have-fewer-genetic-changes-than-expected.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Huntington&#039;s disease: genetic disorder of cognitive and motor decline</title>
		<link>http://www.nanomedicine.tv/gene-therapy/huntingtons-disease-genetic-disorder-of-cognitive-and-motor-decline.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/huntingtons-disease-genetic-disorder-of-cognitive-and-motor-decline.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/huntingtons-disease-genetic-disorder-of-cognitive-and-motor-decline.php</guid>
		<description><![CDATA[Huntington&#039;s disease (HD) is a hereditary neurodegenerative disorder that causes involuntary movements, emotional disturbances and diminished cognitive abilities.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&#38;p=genetic+therapy&#38;eo=UTF-8]]></description>
			<content:encoded><![CDATA[<p>Huntington&#039;s disease (HD) is a hereditary neurodegenerative disorder that causes involuntary movements, emotional disturbances and diminished cognitive abilities.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/huntingtons-disease-genetic-disorder-of-cognitive-and-motor-decline.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Genetic Discoveries and Treatment for Hepatitis C [Viewpoint]</title>
		<link>http://www.nanomedicine.tv/gene-therapy/new-genetic-discoveries-and-treatment-for-hepatitis-c-viewpoint.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/new-genetic-discoveries-and-treatment-for-hepatitis-c-viewpoint.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/new-genetic-discoveries-and-treatment-for-hepatitis-c-viewpoint.php</guid>
		<description><![CDATA[Treatment of chronic hepatitis C (CHC) is a prototype for personalized medicine. Combination therapy with peginterferon alfa plus ribavirin was the standard of care for more than a decade.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&#38;p=genetic+therapy&#38;eo=UTF-8]]></description>
			<content:encoded><![CDATA[<p>Treatment of chronic hepatitis C (CHC) is a prototype for personalized medicine. Combination therapy with peginterferon alfa plus ribavirin was the standard of care for more than a decade.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/new-genetic-discoveries-and-treatment-for-hepatitis-c-viewpoint.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnosing a Rare, Genetic Disease</title>
		<link>http://www.nanomedicine.tv/gene-therapy/diagnosing-a-rare-genetic-disease.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/diagnosing-a-rare-genetic-disease.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/diagnosing-a-rare-genetic-disease.php</guid>
		<description><![CDATA[Five years ago, a one-year-old boy named Connor was brought in for a second opinion. He had gone to a fine pediatrician on the Main Line who knew that something was very wrong, but did not know exactly what.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&#38;p=genetic+therapy&#38;eo=UTF-8]]></description>
			<content:encoded><![CDATA[<p>Five years ago, a one-year-old boy named Connor was brought in for a second opinion. He had gone to a fine pediatrician on the Main Line who knew that something was very wrong, but did not know exactly what.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=genetic+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/diagnosing-a-rare-genetic-disease.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Repost: Depressed mice, gene therapy, and p11</title>
		<link>http://www.nanomedicine.tv/gene-therapy/repost-depressed-mice-gene-therapy-and-p11.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/repost-depressed-mice-gene-therapy-and-p11.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/repost-depressed-mice-gene-therapy-and-p11.php</guid>
		<description><![CDATA[Today’s post is a repost from October 2010. I’ve got some major stuff cooking in the lab right now and I need all of my brain power for it. Enjoy the repost and I shall return! Reader David sent me this paper the other day, and asked if I could blog about it. I said [...]]]></description>
			<content:encoded><![CDATA[<p>Today’s post is a repost from October 2010. I’ve got some major stuff cooking in the lab right now and I need all of my brain power for it. Enjoy the repost and I shall return! Reader David sent me this paper the other day, and asked if I could blog about it. I said ok, maybe, and then I read… [More]Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/repost-depressed-mice-gene-therapy-and-p11.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Penn researchers report a gene-therapy success</title>
		<link>http://www.nanomedicine.tv/gene-therapy/penn-researchers-report-a-gene-therapy-success.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/penn-researchers-report-a-gene-therapy-success.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/penn-researchers-report-a-gene-therapy-success.php</guid>
		<description><![CDATA[For a quarter of a century, gene therapy has been stymied, largely because the patient&#039;s immune system attacks the treatment as a suspected rogue &#8211; or because it actually does turn rogue.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&#38;p=gene+therapy&#38;eo=UTF-8]]></description>
			<content:encoded><![CDATA[<p>For a quarter of a century, gene therapy has been stymied, largely because the patient&#039;s immune system attacks the treatment as a suspected rogue &#8211; or because it actually does turn rogue.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/penn-researchers-report-a-gene-therapy-success.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gene Therapy Safe in Decade-Long HIV Study That May Widen Use</title>
		<link>http://www.nanomedicine.tv/gene-therapy/gene-therapy-safe-in-decade-long-hiv-study-that-may-widen-use.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/gene-therapy-safe-in-decade-long-hiv-study-that-may-widen-use.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/gene-therapy-safe-in-decade-long-hiv-study-that-may-widen-use.php</guid>
		<description><![CDATA[HIV patients given gene therapy more than a decade ago are healthy and the altered DNA they received remains stable in their bodies, according to a study that scientists say proves the treatment may safely be tested as a way to attack other illnesses.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&#38;p=gene+therapy&#38;eo=UTF-8]]></description>
			<content:encoded><![CDATA[<p>HIV patients given gene therapy more than a decade ago are healthy and the altered DNA they received remains stable in their bodies, according to a study that scientists say proves the treatment may safely be tested as a way to attack other illnesses.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/gene-therapy-safe-in-decade-long-hiv-study-that-may-widen-use.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gene therapy for hearing loss: Potential and limitations</title>
		<link>http://www.nanomedicine.tv/gene-therapy/gene-therapy-for-hearing-loss-potential-and-limitations.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/gene-therapy-for-hearing-loss-potential-and-limitations.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/gene-therapy-for-hearing-loss-potential-and-limitations.php</guid>
		<description><![CDATA[Regenerating sensory hair cells could form the basis for treating age- or trauma-related hearing loss. One way to do this could be with gene therapy that drives new sensory hair cells to grow. Researchers have shown that introducing a gene called Atoh1 into the cochleae of young mice can induce the formation of extra sensory [...]]]></description>
			<content:encoded><![CDATA[<p>Regenerating sensory hair cells could form the basis for treating age- or trauma-related hearing loss. One way to do this could be with gene therapy that drives new sensory hair cells to grow. Researchers have shown that introducing a gene called Atoh1 into the cochleae of young mice can induce the formation of extra sensory hair cells.Source:<br /><a href="http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8">http://news.search.yahoo.com/news/rss?ei=UTF-8&amp;p=gene+therapy&amp;eo=UTF-8</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/gene-therapy-for-hearing-loss-potential-and-limitations.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interferon-alpha enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma</title>
		<link>http://www.nanomedicine.tv/gene-therapy/interferon-alpha-enhances-antitumor-activities-of-oncolytic-adenovirus-mediated-il-24-expression-in-hepatocellular-carcinoma.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/interferon-alpha-enhances-antitumor-activities-of-oncolytic-adenovirus-mediated-il-24-expression-in-hepatocellular-carcinoma.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/interferon-alpha-enhances-antitumor-activities-of-oncolytic-adenovirus-mediated-il-24-expression-in-hepatocellular-carcinoma.php</guid>
		<description><![CDATA[Conclusions: The present study demonstrated for the first time the potential antitumor activity of IFN-alpha combined with the oncolytic adenovirus SG600-IL-24 in HCC both in vitro and in vivo, and suggests its further development as a potential candidate for HCC cancer gene therapy. (Source: Molecular Cancer)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml]]></description>
			<content:encoded><![CDATA[<p>Conclusions:<br />
The present study demonstrated for the first time the potential antitumor activity of IFN-alpha combined with the oncolytic adenovirus SG600-IL-24 in HCC both in vitro and in vivo, and suggests its further development as a potential candidate for HCC cancer gene therapy. (Source: Molecular Cancer)Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/interferon-alpha-enhances-antitumor-activities-of-oncolytic-adenovirus-mediated-il-24-expression-in-hepatocellular-carcinoma.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zinc Finger Protein Designed to Target 2-Long Terminal Repeat Junctions Interferes with Human Immunodeficiency Virus Integration</title>
		<link>http://www.nanomedicine.tv/gene-therapy/zinc-finger-protein-designed-to-target-2-long-terminal-repeat-junctions-interferes-with-human-immunodeficiency-virus-integration.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/zinc-finger-protein-designed-to-target-2-long-terminal-repeat-junctions-interferes-with-human-immunodeficiency-virus-integration.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/zinc-finger-protein-designed-to-target-2-long-terminal-repeat-junctions-interferes-with-human-immunodeficiency-virus-integration.php</guid>
		<description><![CDATA[Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml]]></description>
			<content:encoded><![CDATA[<p>Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/zinc-finger-protein-designed-to-target-2-long-terminal-repeat-junctions-interferes-with-human-immunodeficiency-virus-integration.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Shield Against Chemotherapy</title>
		<link>http://www.nanomedicine.tv/gene-therapy/a-shield-against-chemotherapy.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/a-shield-against-chemotherapy.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/a-shield-against-chemotherapy.php</guid>
		<description><![CDATA[Gene therapy protects body while leaving cancer cells vulnerable (Source: ScienceNOW)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml]]></description>
			<content:encoded><![CDATA[<p>Gene therapy protects body while leaving cancer cells vulnerable (Source: ScienceNOW)Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/a-shield-against-chemotherapy.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome</title>
		<link>http://www.nanomedicine.tv/gene-therapy/ubiquitous-high-level-gene-expression-in-hematopoietic-lineages-provides-effective-lentiviral-gene-therapy-of-murine-wiskott-aldrich-syndrome.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/ubiquitous-high-level-gene-expression-in-hematopoietic-lineages-provides-effective-lentiviral-gene-therapy-of-murine-wiskott-aldrich-syndrome.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/ubiquitous-high-level-gene-expression-in-hematopoietic-lineages-provides-effective-lentiviral-gene-therapy-of-murine-wiskott-aldrich-syndrome.php</guid>
		<description><![CDATA[The immunodeficiency disorder Wiskott-Aldrich syndrome (WAS) leads to life-threatening hematopoietic cell dysfunction. We used WAS protein (WASp)&#8211;deficient mice to analyze the in vivo efficacy of lentiviral (LV) vectors using either a viral-derived promoter, MND, or the human proximal WAS promoter (WS1.6) for human WASp expression. Transplantation of stem cells transduced with MND-huWASp LV resulted in [...]]]></description>
			<content:encoded><![CDATA[<p>The immunodeficiency disorder Wiskott-Aldrich syndrome (WAS) leads to life-threatening hematopoietic cell dysfunction. We used WAS protein (WASp)&ndash;deficient mice to analyze the in vivo efficacy of lentiviral (LV) vectors using either a viral-derived promoter, MND, or the human proximal WAS promoter (WS1.6) for human WASp expression. Transplantation of stem cells transduced with MND-huWASp LV resulted in sustained, endogenous levels of WASp in all hematopoietic lineages, progressive selection for WASp+ T, natural killer T and B cells, rescue of T-cell proliferation and cytokine production, and substantial restoration of marginal zone (MZ) B cells. In contrast, WS1.6-huWASp LV recipients exhibited subendogenous WASp expression in all cell types with only partial selection of WASp+ T cel&#8230;Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/ubiquitous-high-level-gene-expression-in-hematopoietic-lineages-provides-effective-lentiviral-gene-therapy-of-murine-wiskott-aldrich-syndrome.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A paradigm shift in the delivery of services for diagnosis of inherited retinal disease</title>
		<link>http://www.nanomedicine.tv/gene-therapy/a-paradigm-shift-in-the-delivery-of-services-for-diagnosis-of-inherited-retinal-disease.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/a-paradigm-shift-in-the-delivery-of-services-for-diagnosis-of-inherited-retinal-disease.php#comments</comments>
		<pubDate>Sun, 13 May 2012 15:56:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/a-paradigm-shift-in-the-delivery-of-services-for-diagnosis-of-inherited-retinal-disease.php</guid>
		<description><![CDATA[Conclusions The new NGS approach delivers a step change in the diagnosis of inherited eye disease, provides precise diagnostic information and extends the possibility of targeted treatments including gene therapy. The approach represents an exemplar that illustrates the opportunity that NGS provides for broadening the availability of genetic testing. The technology will be applied to [...]]]></description>
			<content:encoded><![CDATA[<p>Conclusions<br />
The new NGS approach delivers a step change in the diagnosis of inherited eye disease, provides precise diagnostic information and extends the possibility of targeted treatments including gene therapy. The approach represents an exemplar that illustrates the opportunity that NGS provides for broadening the availability of genetic testing. The technology will be applied to many conditions that are associated with high levels of genetic heterogeneity. (Source: Journal of Medical Genetics)
<div>
<p><b><i>MedWorm Sponsor Message:</i></b> Please support the <a href="http://www.doctorsinchains.org/" target="_blank">Doctors In Chains</a> campaign for the <a href="http://www.doctorsinchains.org/">medics</a> tortured and sentenced for up to 15 years in <a href="http://www.doctorsinchains.org/">Bahrain</a>. <a href="https://twitter.com/#!/search/%23FreeDoctors">#FreeDoctors</a></p>
</div>
<p>Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/a-paradigm-shift-in-the-delivery-of-services-for-diagnosis-of-inherited-retinal-disease.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study: Gene Therapy for HIV Safe, But Effectiveness Still Unclear</title>
		<link>http://www.nanomedicine.tv/gene-therapy/study-gene-therapy-for-hiv-safe-but-effectiveness-still-unclear.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/study-gene-therapy-for-hiv-safe-but-effectiveness-still-unclear.php#comments</comments>
		<pubDate>Sun, 06 May 2012 15:54:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/study-gene-therapy-for-hiv-safe-but-effectiveness-still-unclear.php</guid>
		<description><![CDATA[Title: Study: Gene Therapy for HIV Safe, But Effectiveness Still UnclearCategory: Health NewsCreated: 5/2/2012 4:05:00 PMLast Editorial Review: 5/3/2012 12:00:00 AM (Source: MedicineNet HIV General)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml]]></description>
			<content:encoded><![CDATA[<p>Title: Study: Gene Therapy for HIV Safe, But Effectiveness Still UnclearCategory: Health NewsCreated: 5/2/2012 4:05:00 PMLast Editorial Review: 5/3/2012 12:00:00 AM (Source: MedicineNet HIV General)Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/study-gene-therapy-for-hiv-safe-but-effectiveness-still-unclear.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV Gene Therapy Safe Over Time (CME/CE)</title>
		<link>http://www.nanomedicine.tv/gene-therapy/hiv-gene-therapy-safe-over-time-cmece.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/hiv-gene-therapy-safe-over-time-cmece.php#comments</comments>
		<pubDate>Sun, 06 May 2012 15:54:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/hiv-gene-therapy-safe-over-time-cmece.php</guid>
		<description><![CDATA[(MedPage Today) &#8212; A gene therapy approach to HIV treatment is long-lasting and safe, researchers reported. (Source: MedPage Today Infectious Disease) MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml]]></description>
			<content:encoded><![CDATA[<p>(MedPage Today) &#8212; A gene therapy approach to HIV treatment is long-lasting and safe, researchers reported. (Source: MedPage Today Infectious Disease)
<div>
<p><b><i>MedWorm Sponsor Message:</i></b> Please have a look at this new site driven by MedWorm: <a href="http://www.thebreastcancerdaily.com/" target="_blank">The Breast Cancer Daily</a></p>
</div>
<p>Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/hiv-gene-therapy-safe-over-time-cmece.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nanovector delivery of siRNA for cancer therapy</title>
		<link>http://www.nanomedicine.tv/gene-therapy/nanovector-delivery-of-sirna-for-cancer-therapy.php</link>
		<comments>http://www.nanomedicine.tv/gene-therapy/nanovector-delivery-of-sirna-for-cancer-therapy.php#comments</comments>
		<pubDate>Sun, 06 May 2012 15:54:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene therapy]]></category>

		<guid isPermaLink="false">http://www.nanomedicine.tv/gene-therapy/nanovector-delivery-of-sirna-for-cancer-therapy.php</guid>
		<description><![CDATA[Authors: H Shen, T Sun &#38; M Ferrari (Source: Cancer Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml]]></description>
			<content:encoded><![CDATA[<p>Authors: H Shen, T Sun<br />
          &amp; M Ferrari (Source: Cancer Gene Therapy)Source:<br /><a href="http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml">http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nanomedicine.tv/gene-therapy/nanovector-delivery-of-sirna-for-cancer-therapy.php/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

